All In Biotech

Drug Trial Radar · NCT05690802

The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV

Palonosetron Hydrochloride Capsules (Ruoshan ®) Used to Prevent and Control Chemotherapy for Tumor Patients Real World Study on the Safety of Nausea and Vomiting Reduction

Last checked: Nov 20, 2026Latest source record: Jan 19, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

1,060

Planned (sponsor's estimate)

Start

May 16, 2022

Primary completion

May 30, 2027

Study completion May 30, 2029

Sponsor

Lead sponsor
Xijing HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 19, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To observe and evaluate the safety and effectiveness of Palonosetron hydrochloride capsule in preventing acute nausea and vomiting caused by moderate emetic chemotherapy; The characteristics of the applicable population, clinical medication and clinical benefits of Palonosetron Hydrochloride Capsules were analyzed.

Conditions

  • Nausea and Vomiting

Interventions

  • Palonosetron hydrochloride capsulesDrug

    This protocol only stipulates "Palonosetron capsule containing hydrochloric acid protocol", and does not make uniform provisions on the treatment course, and does not interfere with the actual clinical usage and dosage.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Any adverse event after treatmentTime frame: 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital, the Air Force Medical University

    Xi'an, Shaan'xi, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.